Skiplinks

Medicine put to the test

As an independent scientific institute, IQWiG examines the benefits and harms of medical interventions for patients. We provide information about the advantages and disadvantages of examination and treatment methods in the form of scientific reports and easily understandable health information.

Latest news

Press Releases

Press Releases

Nivolumab in squamous cell carcinoma of the head and neck: added benefit for specific patients

2017-09-01 There is an indication of considerable added benefit in progression up to six months after platinum-based therapy. An added benefit is not proven for progression occurring later.  read more Link to "Nivolumab in squamous cell carcinoma of the head and neck: added benefit for specific patients"

Tenofovir alafenamide in chronic hepatitis B: added benefit not proven, data incomplete

2017-07-03 No added benefit can be derived from the incompletely submitted data for adolescents or adults. The postulated better tolerability is not proven.  read more Link to "Tenofovir alafenamide in chronic hepatitis B: added benefit not proven, data incomplete"

Secukinumab and ixekizumab in psoriasis: considerable added benefit for certain patients

2017-06-01 There were notably more remissions than under the comparator therapies. In future, the analysis of symptoms should not be limited to improvements at one time point.  read more Link to "Secukinumab and ixekizumab in psoriasis: considerable added benefit for certain patients"

Pembrolizumab in non-small cell lung cancer: hint of considerable added benefit

2017-05-15 Good study design allows identification of the relevant subpopulation, in which prolonged overall survival notably outweighs disadvantages in some side effects.  read more Link to "Pembrolizumab in non-small cell lung cancer: hint of considerable added benefit"

High-risk medical devices: IQWiG sees no potential in 6 of 8 cases

2017-03-17 Only case series without informative value are available for most indications. A plausible mode of action is insufficient to attribute a potential.  read more Link to "High-risk medical devices: IQWiG sees no potential in 6 of 8 cases"

loading …

Current commenting procedures (Hearings)

Current commenting procedures (Hearings)

There are no actual comments.


Calls for tenders advertised

Calls for tenders advertised

In general, calls for tenders are published in German. Interested parties can check current calls for tenders on the German website.


Easily understandable information for patients and the general community

Cardiopulmonary resuscitation (CPR): What you need to know

Many of us would be willing to help people in a life-threatening situation. But the thought of actually performing cardiopulmonary resuscitation (CPR) or using a defibrillator on someone who is having a heart attack, for instance, is frightening for some. Find out why there is no need to worry, and how you could help someone who is unconscious and not breathing normally.  read more (Link to "Cardiopulmonary resuscitation (CPR): What you need to know" – opens in a new window)

to top

Glossary entries